The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infectious Disease Diagnostic Testing-Global Market Insights and Sales Trends 2024
Synopsis
The global Infectious Disease Diagnostic Testing market size is expected to reach US$ 21090 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Infectious Disease Diagnostic Testing in various end use industries. The expanding demands from the HIV, HAIs, Respiratory and Tropical Diseases, are propelling Infectious Disease Diagnostic Testing market. Molecular Diagnostic Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the POC Infectious Disease Diagnostics Test segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Disease Diagnostic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infectious Disease Diagnostic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Disease Diagnostic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Disease Diagnostic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Disease Diagnostic Testing covered in this report include Abbott, Abbott, bioMerieux, Diasorin, Roche Diagnostic, BD, Gold Standard Diagnostics, Hologic and Siemens Healthcare Diagnostics, etc.
The global Infectious Disease Diagnostic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Abbott
bioMerieux
Diasorin
Roche Diagnostic
BD
Gold Standard Diagnostics
Hologic
Siemens Healthcare Diagnostics
TECHLAB
Bio-Rad Laboratories
Corgenix
Cepheid
Meridian Bioscience
Global Infectious Disease Diagnostic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Disease Diagnostic Testing market, Segment by Type:
Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test
Global Infectious Disease Diagnostic Testing market, by Application
HIV
HAIs
Respiratory
Tropical Diseases
Liver
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Disease Diagnostic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Infectious Disease Diagnostic Testing market size is expected to reach US$ 21090 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Infectious Disease Diagnostic Testing in various end use industries. The expanding demands from the HIV, HAIs, Respiratory and Tropical Diseases, are propelling Infectious Disease Diagnostic Testing market. Molecular Diagnostic Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the POC Infectious Disease Diagnostics Test segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Disease Diagnostic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infectious Disease Diagnostic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Disease Diagnostic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Disease Diagnostic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Disease Diagnostic Testing covered in this report include Abbott, Abbott, bioMerieux, Diasorin, Roche Diagnostic, BD, Gold Standard Diagnostics, Hologic and Siemens Healthcare Diagnostics, etc.
The global Infectious Disease Diagnostic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Abbott
bioMerieux
Diasorin
Roche Diagnostic
BD
Gold Standard Diagnostics
Hologic
Siemens Healthcare Diagnostics
TECHLAB
Bio-Rad Laboratories
Corgenix
Cepheid
Meridian Bioscience
Global Infectious Disease Diagnostic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Disease Diagnostic Testing market, Segment by Type:
Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test
Global Infectious Disease Diagnostic Testing market, by Application
HIV
HAIs
Respiratory
Tropical Diseases
Liver
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Disease Diagnostic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infectious Disease Diagnostic Testing
1.1 Infectious Disease Diagnostic Testing Market Overview
1.1.1 Infectious Disease Diagnostic Testing Product Scope
1.1.2 Infectious Disease Diagnostic Testing Market Status and Outlook
1.2 Global Infectious Disease Diagnostic Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infectious Disease Diagnostic Testing Market Size by Region (2018-2029)
1.4 Global Infectious Disease Diagnostic Testing Historic Market Size by Region (2018-2023)
1.5 Global Infectious Disease Diagnostic Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infectious Disease Diagnostic Testing Market Size (2018-2029)
1.6.1 North America Infectious Disease Diagnostic Testing Market Size (2018-2029)
1.6.2 Europe Infectious Disease Diagnostic Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Infectious Disease Diagnostic Testing Market Size (2018-2029)
1.6.4 Latin America Infectious Disease Diagnostic Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Infectious Disease Diagnostic Testing Market Size (2018-2029)
2 Infectious Disease Diagnostic Testing Market by Type
2.1 Introduction
2.1.1 Molecular Diagnostic Test
2.1.2 POC Infectious Disease Diagnostics Test
2.2 Global Infectious Disease Diagnostic Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infectious Disease Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infectious Disease Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infectious Disease Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infectious Disease Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infectious Disease Diagnostic Testing Revenue Breakdown by Type (2018-2029)
3 Infectious Disease Diagnostic Testing Market Overview by Application
3.1 Introduction
3.1.1 HIV
3.1.2 HAIs
3.1.3 Respiratory
3.1.4 Tropical Diseases
3.1.5 Liver
3.1.6 Others
3.2 Global Infectious Disease Diagnostic Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infectious Disease Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infectious Disease Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infectious Disease Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infectious Disease Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infectious Disease Diagnostic Testing Revenue Breakdown by Application (2018-2029)
4 Infectious Disease Diagnostic Testing Competition Analysis by Players
4.1 Global Infectious Disease Diagnostic Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2022)
4.3 Date of Key Players Enter into Infectious Disease Diagnostic Testing Market
4.4 Global Top Players Infectious Disease Diagnostic Testing Headquarters and Area Served
4.5 Key Players Infectious Disease Diagnostic Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Disease Diagnostic Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions
5.1.4 Abbott Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions
5.2.4 Abbott Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 bioMerieux
5.3.1 bioMerieux Profile
5.3.2 bioMerieux Main Business
5.3.3 bioMerieux Infectious Disease Diagnostic Testing Products, Services and Solutions
5.3.4 bioMerieux Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Diasorin Recent Developments
5.4 Diasorin
5.4.1 Diasorin Profile
5.4.2 Diasorin Main Business
5.4.3 Diasorin Infectious Disease Diagnostic Testing Products, Services and Solutions
5.4.4 Diasorin Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Diasorin Recent Developments
5.5 Roche Diagnostic
5.5.1 Roche Diagnostic Profile
5.5.2 Roche Diagnostic Main Business
5.5.3 Roche Diagnostic Infectious Disease Diagnostic Testing Products, Services and Solutions
5.5.4 Roche Diagnostic Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Diagnostic Recent Developments
5.6 BD
5.6.1 BD Profile
5.6.2 BD Main Business
5.6.3 BD Infectious Disease Diagnostic Testing Products, Services and Solutions
5.6.4 BD Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.6.5 BD Recent Developments
5.7 Gold Standard Diagnostics
5.7.1 Gold Standard Diagnostics Profile
5.7.2 Gold Standard Diagnostics Main Business
5.7.3 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions
5.7.4 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Gold Standard Diagnostics Recent Developments
5.8 Hologic
5.8.1 Hologic Profile
5.8.2 Hologic Main Business
5.8.3 Hologic Infectious Disease Diagnostic Testing Products, Services and Solutions
5.8.4 Hologic Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Hologic Recent Developments
5.9 Siemens Healthcare Diagnostics
5.9.1 Siemens Healthcare Diagnostics Profile
5.9.2 Siemens Healthcare Diagnostics Main Business
5.9.3 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions
5.9.4 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Siemens Healthcare Diagnostics Recent Developments
5.10 TECHLAB
5.10.1 TECHLAB Profile
5.10.2 TECHLAB Main Business
5.10.3 TECHLAB Infectious Disease Diagnostic Testing Products, Services and Solutions
5.10.4 TECHLAB Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.10.5 TECHLAB Recent Developments
5.11 Bio-Rad Laboratories
5.11.1 Bio-Rad Laboratories Profile
5.11.2 Bio-Rad Laboratories Main Business
5.11.3 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Products, Services and Solutions
5.11.4 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Bio-Rad Laboratories Recent Developments
5.12 Corgenix
5.12.1 Corgenix Profile
5.12.2 Corgenix Main Business
5.12.3 Corgenix Infectious Disease Diagnostic Testing Products, Services and Solutions
5.12.4 Corgenix Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Corgenix Recent Developments
5.13 Cepheid
5.13.1 Cepheid Profile
5.13.2 Cepheid Main Business
5.13.3 Cepheid Infectious Disease Diagnostic Testing Products, Services and Solutions
5.13.4 Cepheid Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Cepheid Recent Developments
5.14 Meridian Bioscience
5.14.1 Meridian Bioscience Profile
5.14.2 Meridian Bioscience Main Business
5.14.3 Meridian Bioscience Infectious Disease Diagnostic Testing Products, Services and Solutions
5.14.4 Meridian Bioscience Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Meridian Bioscience Recent Developments
6 North America
6.1 North America Infectious Disease Diagnostic Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostic Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infectious Disease Diagnostic Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infectious Disease Diagnostic Testing Market Dynamics
11.1 Infectious Disease Diagnostic Testing Industry Trends
11.2 Infectious Disease Diagnostic Testing Market Drivers
11.3 Infectious Disease Diagnostic Testing Market Challenges
11.4 Infectious Disease Diagnostic Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
